These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7972553)

  • 1. [The use of carbamazepine in affective disorders].
    Beresewicz M
    Psychiatr Pol; 1994; 28(4):455-66. PubMed ID: 7972553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders.
    Fritze J; Beneke M; Lanczik M; Schneider B; Walden J
    Pharmacopsychiatry; 1994 Sep; 27(5):181-5. PubMed ID: 7838887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of carbamazepine in psychiatric disorders.
    Birkhimer LJ; Curtis JL; Jann MW
    Clin Pharm; 1985; 4(4):425-34. PubMed ID: 2864160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The lithium concentration of the blood plasma in combined therapy with lithium carbonate and carbamazepine].
    Skorik AI
    Farmakol Toksikol; 1991; 54(4):57-9. PubMed ID: 1786831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrooculography and dark adaptation in patients with affective and schizoaffective psychoses: early physiological effects of carbamazepine and lithium.
    Kaschka WP; Thürauf N; Mokrusch T; Korth M
    Pharmacopsychiatry; 1988 Nov; 21(6):404-6. PubMed ID: 3244776
    [No Abstract]   [Full Text] [Related]  

  • 6. [Investigation on the therapeutic effect of carbamazepine on the mood disorders in Japan].
    Okuma T
    Seishin Shinkeigaku Zasshi; 2005; 107(5):415-22. PubMed ID: 15981617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
    Dardennes R; Lafuma A; Watkins S
    Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders.
    Lenzi A; Lazzerini F; Placidi GF; Cassano GB; Akiskal HS
    Pharmacopsychiatry; 1989 Jan; 22(1):34-7. PubMed ID: 2652160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine.
    Friedman DL; Kastner T; Plummer AT; Ruiz MQ; Henning D
    Am J Ment Retard; 1992 Mar; 96(5):541-6. PubMed ID: 1562312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization and oscillation following repeated stimulation: relationship to affective illness and its treatment with lithium and carbamazepine [proceedings].
    Post RM
    Psychopharmacol Bull; 1980 Oct; 16(4):50-2. PubMed ID: 7454937
    [No Abstract]   [Full Text] [Related]  

  • 11. Divalproex sodium in the treatment of refractory affective disorders.
    Schaff MR; Fawcett J; Zajecka JM
    J Clin Psychiatry; 1993 Oct; 54(10):380-4. PubMed ID: 8262880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative evaluation of clinical and economic effectiveness of preventive therapy of affective and schizoaffective psychoses].
    Ushakov IuV; Kostiukova EG; Kalugina LI; Mirzoian MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):79-82. PubMed ID: 2176049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.
    Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J
    J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring plasma levels of carbamazepine. A pharmacokinetic study in patients with affective disorders.
    Nolen WA; Jansen GS; Broekman M
    Pharmacopsychiatry; 1988 Sep; 21(5):252-4. PubMed ID: 3227056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamazepine in the prophylaxis of major depression: a 5-year follow-up.
    Stuppaeck CH; Barnas C; Schwitzer J; Fleischhacker WW
    J Clin Psychiatry; 1994 Apr; 55(4):146-50. PubMed ID: 8071258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Labial herpes in patients with affective disorders receiving long-term lithium carbonate].
    Rybakowski J; Strzyzewski W; Zelechowska-Ruda E; Chłopocka-Woźniak M
    Pol Tyg Lek; 1993 Mar 1-8; 48(9-10):215-7. PubMed ID: 8234051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic use of carbamazepine for treatment of agitation and affective disorders in geriatric psychiatry patients].
    Lemke MR; Stuhlmann W
    Psychiatr Prax; 1994 Jul; 21(4):147-50. PubMed ID: 7938323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A clinical study on combined lithium and carbamazepine treatment of major affective disorders].
    Chen CC; Ko WK
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Mar; 3(3):176-81. PubMed ID: 3482282
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of carbamazepine in polyuria associated with lithium therapy.
    Ghose K
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Sep; 11(5):241-5. PubMed ID: 360249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.